Report cover image

The World Molecular Diagnostics Market - 7th Edition (HIV Testing, Hepatitis Testing, Molecular Cancer Tests, Blood Screening, Hospital-Acquired Tests, RSV, CT/NG, HPV, Inherited Diseases, ISH)

Publisher Kalorama Information
Published Jan 30, 2017
Length 353 Pages
SKU # KLI15232978

Description

World Molecular Diagnostics Market

This Kalorama Information report, The World Molecular Diagnostics Market, examines the current state for molecular assays, including cancer tests, NAT blood screening, transplantation testing, histology testing and inherited disease testing. Market size and forecasts are provided to 2021 for major segments and several subsegments. Profiles of operators and market share is provided.

As part of its coverage, the following market estimates are included in this report:

  Microbiology Market, 2016-2021
  Oncology Testing Market 2016-2021
  Blood Screening Market 2016-2012
  Infectious Disease Molecular Diagnostics Markets:
     Hepatitis Test Market
     HIV Diagnostics Market, 2016 to 2021
     HAIs/Sepsis Market, 2016 to 2021
     CT/NG Diagnostics Market, 2016 to 2021
     HPV Diagnostics Market, 2016 to 2021
     RSV Diagnostics Market, 2016 to 2021
     Mycobacteria/TB Molecular Diagnostics Market, 2016 to 2021
     Other Infectious Disease Molecular Diagnostics Market, 2016 to 2021
  ISH Market by Application: Genetic, Cancer, Other, 2016 to 2021
  Other Histology Molecular Diagnostics Market, 2016 to 2021
  Inherited Diseases Molecular Diagnostics Market, 2016 to 2021
  Transplant Diagnostics Market, 2016 to 2021
 

The major applications of clinical molecular diagnostics include the following:

• Infectious disease diagnostics - molecular microbiology and virology, including the detection, identification, quantification and nucleic-acid based resistance or susceptibility profiling of pathogens
• Blood transfusion diagnostics - nucleic acid screening (NAT) of donated blood, often pooled samples, for the detection of active infections responsible for transfusion transmitted infections (TTIs); ancillary market for molecular immunohematology or blood typing
• Histology / cytology diagnostics - largely synonymous with in situ hybridization (ISH) methods that use direct hybridization of chromogenic (CISH) or fluorescent (FISH) nucleic acid probes within slided tissue or suspended cell samples viewed under microscopy; ISH applications primarily include cancer testing and cytogenetics or chromosomal study
• Cancer diagnostics - tissue, blood and urine samples can be assayed using nucleic acid amplification tests (NAATs) or sequencing to diagnose, prognose and identify key mutations for targeted therapies; future additional capabilities are premised on liquid biopsy sampling (non-invasive fluid samples such as venous blood or urine) and next-generation sequencing (NGS) and include early cancer detection (including recurrence), therapy monitoring (remission)
• Transplant diagnostics - various PCR-based methodologies, Sanger sequencing and NGS used to type HLA alleles in low to high resolution in order to match donors and recipients for solid organ and hematopoietic stem cell (HSCT) or bone marrow transplants; post-transplant monitoring including for transplant rejection is an ancillary testing area
• Inherited disease diagnostics - diagnosis of rare genetic diseases and other inherited traits including pharmacodiagnostic (pharmacokinetic) traits; major area of application is thrombophilia markers and anticoagulant response markers


All of these areas are covered in Kalorama Information's 7th Edition report.   

Advantages of Kalorama Information's report include:

- Market Share Analysis - This report contains market share analysis for each segment of molecular diagnostics.  (inherited diseases contains a great number of tests, and thus key players in disease areas are discussed rather than market share computation).
- Company Profiles - the report fully functions as a benchmarking tool, providing recent revenue performance, product launches, acquisitions for every significant competitor in the market. 
-Forecasts for each category of the market.   
-Industry Focus - Kalorama reports are industry-focused, they are based on events in the industry and not on academic configurations or economic models. 
-Expert Analyst - Kalorama reports are written by an expert group of analysts with combined decades of experience in IVD, biotech and medical device markets.  These analysts are able to read between the lines, triangulate hard to discover data and sort through company hype.  
-Healthcare only focus - Kalorama publishes only in healthcare.  We track these markets on a regular basis and have sources in the industry that other competitors are too scattered in focus to maintain.  Our brand as a top IVD, biotech and medical device market research publisher enables us to have unbiased conversations with industry and to provide independent analysis that in-house company research cannot produce.  

Table of Contents

353 Pages
    • Introduction
    • Molecular Diagnostic Technologies
    • Molecular Diagnostics in Healthcare
    • Global Molecular Diagnostics Market
    • Major Conclusions
    • Introduction
    • Nucleic Acid Amplification Test (NAAT) Technologies
    • Microarrays
    • In Situ Hybridization (ISH)
    • Sequencing
    • Conclusions
    • Introduction
    • Reimbursement Environment for Molecular Diagnostics
    • Molecular Diagnostics and the Clinical Utility Standard
    • Laboratory-Developed Tests Are Here to Stay
    • Conclusions
    • Market-Available Molecular Diagnostic Platforms - POC, Hospital and Developing World (Vendor, Assay Menu, Planned Assays, Regulatory Status, Procedure Integration, Test Principles)
    • Market Analysis
    • CT/NG, HPV and Women's Health
    • Hepatitis
    • HIV
    • Hospital-Acquired Infections (HAIs) and Sepsis
    • Respiratory
    • Tuberculosis
    • Conclusions
    • Introduction
    • Market Analysis
    • New Infectious Disease Threats and Assay Introduction
    • Conclusions
    • Introduction
    • Market Analysis
    • RNA in Molecular Histology
    • CISH and Other Reagent Chemistries
    • Prenatal Testing moves to NIPT
    • Conclusions
    • Introduction
    • Bringing Molecular Resolution to Cancer Diagnostics
    • Tissue-Based Diagnostics, Companion Assays and the Status Quo in IVD
    • Market Analysis
    • U.S. Market
    • EU Market
    • Chinese Market
    • Rest of the World
    • Conclusions
    • Introduction
    • Market Analysis
    • Technological Shift to Next-Generation Sequencing and Real-Time PCR
    • Conclusions
    • Market Analysis
    • Thrombophilia and Coagulation Markers
    • Autism
    • Alzheimer's Disease
    • Cardiovascular Disease
    • Diabetes
    • Psychiatric Disorders
    • Gastrointestinal Conditions
    • Other Autoimmune Diseases
    • Conclusions
    • Market Summary
    • Major Conclusions
    • Abbott Diagnostics
    • Advanced Cell Diagnostics
    • Affymetrix (Thermo Fisher Scientific)
    • Agilent Technologies
    • Alere
    • Amoy Diagnostics
    • Applied Spectral Imaging
    • Beckman Coulter (Danaher)
    • Becton, Dickinson & Co. (BD)
    • Beijing Genomics Institute (BGI)
    • Berry Genomics
    • Biocartis
    • bioMérieux
    • Bio-Rad Laboratories
    • BioView
    • CareDx
    • Cepheid (Danaher)
    • Covaris
    • Dako (Agilent Technologies)
    • Eiken Chemical
    • Epigenomics
    • Exosome Diagnostics
    • GenMark Diagnostics
    • Grifols
    • Hologic
    • Illumina
    • Immucor
    • Janssen Diagnostics (Johnson & Johnson)
    • Leica Biosystems (Danaher)
    • Luminex Corporation
    • Meridian Bioscience
    • Nanosphere (Luminex)
    • NanoString Technologies
    • Qiagen
    • Quidel
    • Roche Diagnostics
    • Siemens Healthcare Diagnostics
    • Thermo Fisher Scientific
    • Vela Diagnostics
    • Ventana Medical Systems (Roche)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us